Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029

Publisher Name :
Date: 28-Jun-2023
No. of pages: 88
Inquire Before Buying

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

Market Analysis and Insights: Global Overactive Bladder Therapeutics Market

The global Overactive Bladder Therapeutics market is projected to grow from US$ 5240.8 million in 2023 to US$ 6042.2 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.4% during the forecast period.

Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.

Report Includes

This report presents an overview of global market for Overactive Bladder Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Overactive Bladder Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Overactive Bladder Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Overactive Bladder Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Overactive Bladder Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Overactive Bladder Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Astellas Pharma, Allergan, Pfizer, Johnson & Johnson and Teva (Activas), etc.

By Company

- Astellas Pharma

- Allergan

- Pfizer

- Johnson & Johnson

- Teva (Activas)

Segment by Type

- Anticholinergics

- Mirabegron

- Botox

Segment by Application

- Idiopathic Overactive Bladder

- Neurogenic Overactive Bladder

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Overactive Bladder Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Overactive Bladder Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Overactive Bladder Therapeutics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Overactive Bladder Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.3 Market by Application
1.3.1 Global Overactive Bladder Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Overactive Bladder Therapeutics Market Perspective (2018-2029)
2.2 Global Overactive Bladder Therapeutics Growth Trends by Region
2.2.1 Overactive Bladder Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Overactive Bladder Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Overactive Bladder Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Overactive Bladder Therapeutics Market Dynamics
2.3.1 Overactive Bladder Therapeutics Industry Trends
2.3.2 Overactive Bladder Therapeutics Market Drivers
2.3.3 Overactive Bladder Therapeutics Market Challenges
2.3.4 Overactive Bladder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Overactive Bladder Therapeutics by Players
3.1.1 Global Overactive Bladder Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Overactive Bladder Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Overactive Bladder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Overactive Bladder Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Overactive Bladder Therapeutics Market Concentration Ratio
3.4.1 Global Overactive Bladder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Therapeutics Revenue in 2022
3.5 Global Key Players of Overactive Bladder Therapeutics Head office and Area Served
3.6 Global Key Players of Overactive Bladder Therapeutics, Product and Application
3.7 Global Key Players of Overactive Bladder Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Overactive Bladder Therapeutics Breakdown Data by Type
4.1 Global Overactive Bladder Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Overactive Bladder Therapeutics Forecasted Market Size by Type (2024-2029)
5 Overactive Bladder Therapeutics Breakdown Data by Application
5.1 Global Overactive Bladder Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Overactive Bladder Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Overactive Bladder Therapeutics Market Size (2018-2029)
6.2 North America Overactive Bladder Therapeutics Market Size by Type
6.2.1 North America Overactive Bladder Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Overactive Bladder Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Overactive Bladder Therapeutics Market Share by Type (2018-2029)
6.3 North America Overactive Bladder Therapeutics Market Size by Application
6.3.1 North America Overactive Bladder Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Overactive Bladder Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Overactive Bladder Therapeutics Market Share by Application (2018-2029)
6.4 North America Overactive Bladder Therapeutics Market Size by Country
6.4.1 North America Overactive Bladder Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Overactive Bladder Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Overactive Bladder Therapeutics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Overactive Bladder Therapeutics Market Size (2018-2029)
7.2 Europe Overactive Bladder Therapeutics Market Size by Type
7.2.1 Europe Overactive Bladder Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Overactive Bladder Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Overactive Bladder Therapeutics Market Share by Type (2018-2029)
7.3 Europe Overactive Bladder Therapeutics Market Size by Application
7.3.1 Europe Overactive Bladder Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Overactive Bladder Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Overactive Bladder Therapeutics Market Share by Application (2018-2029)
7.4 Europe Overactive Bladder Therapeutics Market Size by Country
7.4.1 Europe Overactive Bladder Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Overactive Bladder Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Overactive Bladder Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Overactive Bladder Therapeutics Market Size (2018-2029)
8.2 China Overactive Bladder Therapeutics Market Size by Type
8.2.1 China Overactive Bladder Therapeutics Market Size by Type (2018-2023)
8.2.2 China Overactive Bladder Therapeutics Market Size by Type (2024-2029)
8.2.3 China Overactive Bladder Therapeutics Market Share by Type (2018-2029)
8.3 China Overactive Bladder Therapeutics Market Size by Application
8.3.1 China Overactive Bladder Therapeutics Market Size by Application (2018-2023)
8.3.2 China Overactive Bladder Therapeutics Market Size by Application (2024-2029)
8.3.3 China Overactive Bladder Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Overactive Bladder Therapeutics Market Size (2018-2029)
9.2 Asia Overactive Bladder Therapeutics Market Size by Type
9.2.1 Asia Overactive Bladder Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Overactive Bladder Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Overactive Bladder Therapeutics Market Share by Type (2018-2029)
9.3 Asia Overactive Bladder Therapeutics Market Size by Application
9.3.1 Asia Overactive Bladder Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Overactive Bladder Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Overactive Bladder Therapeutics Market Share by Application (2018-2029)
9.4 Asia Overactive Bladder Therapeutics Market Size by Region
9.4.1 Asia Overactive Bladder Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Overactive Bladder Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Overactive Bladder Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Overactive Bladder Therapeutics Introduction
11.1.4 Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2018-2023)
11.1.5 Astellas Pharma Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Overactive Bladder Therapeutics Introduction
11.2.4 Allergan Revenue in Overactive Bladder Therapeutics Business (2018-2023)
11.2.5 Allergan Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Overactive Bladder Therapeutics Introduction
11.3.4 Pfizer Revenue in Overactive Bladder Therapeutics Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Overactive Bladder Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 Teva (Activas)
11.5.1 Teva (Activas) Company Details
11.5.2 Teva (Activas) Business Overview
11.5.3 Teva (Activas) Overactive Bladder Therapeutics Introduction
11.5.4 Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2018-2023)
11.5.5 Teva (Activas) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Overactive Bladder Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Anticholinergics
Table 3. Key Players of Mirabegron
Table 4. Key Players of Botox
Table 5. Global Overactive Bladder Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Overactive Bladder Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Overactive Bladder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Overactive Bladder Therapeutics Market Share by Region (2018-2023)
Table 9. Global Overactive Bladder Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Overactive Bladder Therapeutics Market Share by Region (2024-2029)
Table 11. Overactive Bladder Therapeutics Market Trends
Table 12. Overactive Bladder Therapeutics Market Drivers
Table 13. Overactive Bladder Therapeutics Market Challenges
Table 14. Overactive Bladder Therapeutics Market Restraints
Table 15. Global Overactive Bladder Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Overactive Bladder Therapeutics Revenue Share by Players (2018-2023)
Table 17. Global Top Overactive Bladder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Therapeutics as of 2022)
Table 18. Global Overactive Bladder Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Overactive Bladder Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Overactive Bladder Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Overactive Bladder Therapeutics, Product and Application
Table 22. Global Key Players of Overactive Bladder Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Overactive Bladder Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Overactive Bladder Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Overactive Bladder Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Overactive Bladder Therapeutics Revenue Share by Application (2018-2023)
Table 30. Global Overactive Bladder Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Overactive Bladder Therapeutics Revenue Share by Application (2024-2029)
Table 32. North America Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Overactive Bladder Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Overactive Bladder Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Overactive Bladder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Overactive Bladder Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Overactive Bladder Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Overactive Bladder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Overactive Bladder Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Overactive Bladder Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Overactive Bladder Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Overactive Bladder Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Overactive Bladder Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Overactive Bladder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Overactive Bladder Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 64. Astellas Pharma Company Details
Table 65. Astellas Pharma Business Overview
Table 66. Astellas Pharma Overactive Bladder Therapeutics Product
Table 67. Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Astellas Pharma Recent Developments
Table 69. Allergan Company Details
Table 70. Allergan Business Overview
Table 71. Allergan Overactive Bladder Therapeutics Product
Table 72. Allergan Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Allergan Recent Developments
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Overactive Bladder Therapeutics Product
Table 77. Pfizer Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Developments
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Overactive Bladder Therapeutics Product
Table 82. Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Johnson & Johnson Recent Developments
Table 84. Teva (Activas) Company Details
Table 85. Teva (Activas) Business Overview
Table 86. Teva (Activas) Overactive Bladder Therapeutics Product
Table 87. Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Teva (Activas) Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Overactive Bladder Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Overactive Bladder Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Anticholinergics Features
Figure 4. Mirabegron Features
Figure 5. Botox Features
Figure 6. Global Overactive Bladder Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Overactive Bladder Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Idiopathic Overactive Bladder Case Studies
Figure 9. Neurogenic Overactive Bladder Case Studies
Figure 10. Overactive Bladder Therapeutics Report Years Considered
Figure 11. Global Overactive Bladder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Overactive Bladder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Overactive Bladder Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Overactive Bladder Therapeutics Market Share by Players in 2022
Figure 15. Global Top Overactive Bladder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Overactive Bladder Therapeutics Revenue in 2022
Figure 17. North America Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Overactive Bladder Therapeutics Market Share by Type (2018-2029)
Figure 19. North America Overactive Bladder Therapeutics Market Share by Application (2018-2029)
Figure 20. North America Overactive Bladder Therapeutics Market Share by Country (2018-2029)
Figure 21. United States Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Overactive Bladder Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Overactive Bladder Therapeutics Market Share by Type (2018-2029)
Figure 25. Europe Overactive Bladder Therapeutics Market Share by Application (2018-2029)
Figure 26. Europe Overactive Bladder Therapeutics Market Share by Country (2018-2029)
Figure 27. Germany Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Overactive Bladder Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Overactive Bladder Therapeutics Market Share by Type (2018-2029)
Figure 35. China Overactive Bladder Therapeutics Market Share by Application (2018-2029)
Figure 36. Asia Overactive Bladder Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Overactive Bladder Therapeutics Market Share by Type (2018-2029)
Figure 38. Asia Overactive Bladder Therapeutics Market Share by Application (2018-2029)
Figure 39. Asia Overactive Bladder Therapeutics Market Share by Region (2018-2029)
Figure 40. Japan Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Overactive Bladder Therapeutics Market Share by Country (2018-2029)
Figure 50. Brazil Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Overactive Bladder Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Astellas Pharma Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
Figure 57. Allergan Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
Figure 60. Teva (Activas) Revenue Growth Rate in Overactive Bladder Therapeutics Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Overactive Bladder Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Overactive Bladder Treatment market size was valued at US$ 4989.1 million in 2023. With growing demand in downstream market, the Overactive Bladder Treatment is forecast to a readjusted size of US$ 6182.8 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Overactive Bladder Treatment market. Overactive Bladder Treatment are expected to show stable growth......
  • Global Genitourinary Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Genitourinary Drugs market: According to our latest research, the global Genitourinary Drugs market looks promising in the next 5 years. As of 2022, the global Genitourinary Drugs market was estimated at USD 30442.38 million, and it's anticipated to reach USD 32574.96 million in 2028, with a CAGR of 1.13% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Urinary Tract Infection Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Urinary Tract Infection Treatment market: According to our latest research, the global Urinary Tract Infection Treatment market looks promising in the next 5 years. As of 2022, the global Urinary Tract Infection Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. A urinary tract infection is an infection that can occur in any area of the urinary tract, i......
  • Global Overactive Bladder Treatment Market Research Report 2023, Forecast to 2028
    Published: 02-Nov-2023        Price: US 2680 Onwards        Pages: 130
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Overactive Bladder Treatment Professional Survey Report 2023, Forecast to 2028
    Published: 02-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Overactive Bladder Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 17-Oct-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Overactive Bladder Treatment market: According to our latest research, the global Overactive Bladder Treatment market looks promising in the next 5 years. As of 2022, the global Overactive Bladder Treatment market was estimated at USD 3983.87 million, and it's anticipated to reach USD 5304.63 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Genitourinary Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 150
    Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the genitourinary deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of genitourinary deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Underst......
  • Global Genitourinary Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 70
    The global Genitourinary Drugs market is projected to grow from US$ 29570 million in 2023 to US$ 35930 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period. The US & Canada market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Genitourinary Drugs is estimated to increase from $ million in 202......
  • Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029
    Published: 28-Jun-2023        Price: US 4900 Onwards        Pages: 88
    Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device. Market Analysis and Insights: Global Overactive Bladder Therapeutics Market The global Overactive Bladder Therapeutics market is projected to grow from US$ 5240.8 million in 2023 t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs